Glenn Pierce Voyager Therapeutics, Inc. (VYGR) insider trading activity

VYGR Quotes by TradingView

Glenn Pierce is Director of Voyager Therapeutics, Inc.. Currently has a direct ownership of 16,788 shares of VYGR, which is worth approximately $100,560. The most recent transaction as insider was on Jul 14, 2022, when has been sold 9,512 shares (Common Stock) at a price of $6.7 per share, resulting in proceeds of $63,730. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.8K
0% 3M change
0% 12M change
Total Value Held $100,560

GLENN PIERCE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 14 2022
SELL
Open market or private sale
$63,730 $6.7 p/Share
9,512 Reduced 36.17%
16,788 Common Stock
Jan 13 2022
BUY
Grant, award, or other acquisition
-
26,300 Added 50.0%
26,300 Common Stock

Also insider at

GBT
Global Blood Therapeutics, Inc. Healthcare
Director
GP

Glenn Pierce

Director
Cambridge, MA

Track Institutional and Insider Activities on VYGR

Follow Voyager Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VYGR shares.

Notify only if

Insider Trading

Get notified when an Voyager Therapeutics, Inc. insider buys or sells VYGR shares.

Notify only if

News

Receive news related to Voyager Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VYGR